Companion Animal Genomics & DNA Testing Market Forecasts to 2032 - Global Analysis By Test Type, Animal Type, Distribution Channel, Technology, Application, End User and By Geography

According to Stratistics MRC, the Global Companion Animal Genomics & DNA Testing Market is accounted for $864.55 million in 2025 and is expected to reach $1,510.75 million by 2032 growing at a CAGR of 8.3% during the forecast period. Companion Animal Genomics & DNA Testing refers to the scientific analysis of genetic material in pets such as dogs and cats to understand their breed composition, inherited traits, health risks, and ancestry. Built on decades of classical genetics and modern molecular biology, it applies advanced DNA sequencing and bioinformatics to support preventive healthcare, personalized nutrition, responsible breeding, and disease management. This field enables veterinarians, breeders, and pet owners to anticipate hereditary conditions, optimize wellness plans, and improve quality of life. As technology advances, it is shaping the future of precision veterinary care while preserving the time-honored bond between humans and their companion animals.

Market Dynamics:

Driver:

Rising Pet Ownership & Humanization of Pets

Rising pet ownership, coupled with the deepening emotional bond between humans and their companion animals, is a major growth driver for the market. Pets are increasingly viewed as family members, prompting owners to invest in advanced healthcare, wellness monitoring, and preventive diagnostics. Genetic testing helps owners understand breed traits, behavioral tendencies, and inherited health risks early, enabling proactive care. This long-standing love for animals, now reinforced by modern science, continues to fuel sustained demand for genomics-based pet solutions.

Restraint:

High Cost of Genetic Testing

The high cost associated with companion animal genetic testing acts as a notable market restraint, particularly in price-sensitive regions. Advanced DNA sequencing, bioinformatics analysis, and laboratory infrastructure significantly increase testing expenses. For many pet owners, especially in emerging economies, these costs limit adoption despite growing awareness. Additionally, premium pricing restricts routine or repeat testing, slowing market penetration. Until testing becomes more affordable, cost barriers will continue to challenge widespread market expansion.

Opportunity:

Advances in Technologies

Rapid advancements in genomic technologies present a strong opportunity for market growth. Innovations in next-generation sequencing, SNP genotyping, AI-driven analytics, and cloud-based bioinformatics are improving accuracy while reducing turnaround time. These technological improvements are also lowering operational costs, enabling broader accessibility. As testing platforms become more efficient and user-friendly, companies can expand offerings beyond breed identification to disease prediction, nutrition planning, and personalized care, opening new revenue streams across veterinary and consumer markets.

Threat:

Regulatory & Ethical Challenges

Regulatory and ethical challenges pose a potential threat to the market. Variations in genetic data protection laws, veterinary regulations, and testing standards across regions complicate commercialization. Ethical concerns surrounding data ownership, genetic discrimination in breeding, and misuse of pet DNA information further intensify scrutiny. Companies must navigate evolving compliance frameworks while maintaining transparency and trust. Failure to address these issues could slow approvals, and impact long-term market credibility.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the companion animal genomics and DNA testing market. While supply chain disruptions and temporary laboratory closures slowed operations initially, lockdowns triggered a surge in pet adoption globally. Increased time spent with pets heightened owner awareness of pet health and wellness, accelerating interest in genetic testing. Post-pandemic recovery has strengthened demand, with digital ordering, at-home sample kits, and tele-veterinary integration supporting market resilience and long-term growth.

The breed identification testing segment is expected to be the largest during the forecast period

The breed identification testing segment is expected to account for the largest market share during the forecast period, due to strong consumer demand and widespread awareness. Pet owners increasingly seek insights into breed composition to better understand behavior, size expectations, and potential health risks. This segment benefits from direct-to-consumer test kits, simplified reporting, and strong marketing by leading players. Its affordability and immediate, tangible value make breed identification the most widely adopted entry point into companion animal genomics.

The SNP genotyping segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the SNP genotyping segment is predicted to witness the highest growth rate, due to its superior accuracy and expanding clinical applications. SNP-based testing enables precise detection of genetic variations linked to inherited diseases, traits, and drug responses. Growing adoption by veterinary clinics and breeders for advanced diagnostics and preventive care supports rapid growth. As costs decline and data interpretation improves, SNP genotyping is emerging as the backbone technology for precision veterinary medicine.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rising pet ownership, urbanization, and expanding middle-class populations. Increasing awareness of pet healthcare, coupled with growing veterinary infrastructure and digital pet services, supports market dominance. Countries such as China, Japan, and Australia are witnessing rapid adoption of genetic testing solutions. Strong growth in companion animal spending and improving access to advanced diagnostics underpin the region's leadership.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced veterinary infrastructure, high pet healthcare expenditure, and early adoption of genomic technologies. Strong presence of key market players, widespread availability of direct-to-consumer testing kits, and high awareness among pet owners accelerate growth. Additionally, ongoing research, innovation, and integration of genomics into routine veterinary practice position North America as the fastest-growing regional market.

Key players in the market

Some of the key players in Companion Animal Genomics & DNA Testing Market include Neogen Corporation, UC Davis Veterinary Genetics Laboratory, Zoetis Inc., ZOOGEN, IDEXX Laboratories, Generatio GmbH, Thermo Fisher Scientific, VetGen LLC, Mars Petcare, Eurofins Scientific, Embark Veterinary, Antech Diagnostics, Basepaws, Animal Genetics Inc. and Orivet Genetic Pet Care.

Key Developments:

In October 2025, Mars Petcare and Big Idea Ventures have hand-picked three innovative startups for their 2025 Next Generation Pet Food Program, spotlighting sustainable biotech ingredients and circular feed solutions to transform pet nutrition and reduce environmental impact.

In March 2025, Mars, Incorporated has extended its partnership with the Washington Spirit, becoming the team's Official Petcare Partner, with its logo featured on jerseys and signage, community ticket donations, pet-friendly game nights, and collaborative fan and pet experiences.

Test Types Covered:

• Breed Identification Testing
• Genetic Health Risk Testing
• Disease Screening & Carrier Testing
• Trait & Ancestry Testing
• Wellness & Nutrition Genomics

Animal Types Covered:

• Dogs
• Cats
• Horses
• Other Animal Types

Distribution Channels Covered:

• Direct-to-Consumer (DTC)
• Veterinary Referral Testing
• Online Platforms
• Diagnostic Laboratories

Technologies Covered:

• PCR-based Testing
• Next-Generation Sequencing (NGS)
• SNP Genotyping
• Microarray Technology
• Whole Genome Sequencing

Applications Covered:

• Disease Prediction & Prevention
• Personalized Treatment Planning
• Breeding Management
• Behavioral & Trait Analysis

End Users Covered:

• Veterinary Clinics & Hospitals
• Pet Owners
• Research Institutions
• Breeders & Kennel Clubs

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances